| 1 |
Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study |
|
|
| Peter Y. M. Woo, Tiffany H. P. Law, Kelsey K. Y. Lee, Joyce S. W. Chow, Lai-Fung Li, Sarah S. N. Lau, Tony K. T. Chan, Jason M. K. Ho, Michael W. Y. Lee, Danny T. M. Chan, Wai-Sang Poon |
|
| British Journal of Neurosurgery. 2023; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
BMX, a specific HDAC8 inhibitor, with TMZ for advanced CRC therapy: a novel synergic effect to elicit p53-, ß-catenin- and MGMT-dependent apoptotic cell death |
|
|
| Huey-Jiun Ko, Shean-Jaw Chiou, Cheng-Yu Tsai, Joon-Khim Loh, Xin-Yi Lin, Thu-Ha Tran, Chia-Chung Hou, Tai-Shan Cheng, Jin-Mei Lai, Peter Mu-Hsin Chang, Feng-Sheng Wang, Chun-Li Su, Chi-Ying F. Huang, Yi-Ren Hong |
|
| Cell Communication and Signaling. 2022; 20(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase Inhibitors |
|
|
| Federica Fabro, Martine L. M. Lamfers, Sieger Leenstra |
|
| Cancers. 2022; 14(3): 600 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Theranostic Potential of Adaptive Cold Atmospheric Plasma with Temozolomide to Checkmate Glioblastoma: An In Vitro Study |
|
|
| Vikas Soni, Manish Adhikari, Li Lin, Jonathan H. Sherman, Michael Keidar |
|
| Cancers. 2022; 14(13): 3116 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment |
|
|
| Izadora de Souza, Maria Carolina Clares Ramalho, Camila Banca Guedes, Isabeli Yumi Araújo Osawa, Linda Karolynne Seregni Monteiro, Luciana Rodrigues Gomes, Clarissa Ribeiro Reily Rocha |
|
| International Journal of Molecular Sciences. 2022; 23(13): 6879 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas |
|
|
| Shalini Sundramurthi Chelliah,Ervin Ashley Lourdes Paul,Muhamad Noor Alfarizal Kamarudin,Ishwar Parhar |
|
| Molecules. 2021; 26(4): 1169 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas |
|
|
| Xueyuan Sun,Sevin Turcan |
|
| Cells. 2021; 10(5): 1225 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Temozolomide Induces Endocytosis of EGFRvIII via p38-Mediated Non-canonical Phosphorylation in Glioblastoma Cells |
|
|
| Ratna Dini Haryuni, Tomohiro Tanaka, Jun-ichiro Takahashi, Iimi Onuma, Yue Zhou, Satoru Yokoyama, Hiroaki Sakurai |
|
| Biological and Pharmaceutical Bulletin. 2021; 44(11): 1681 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Approaching Sites of Action of Temozolomide for Pharmacological and Clinical Studies in Glioblastoma |
|
|
| Margaux Fresnais, Sevin Turcan, Dirk Theile, Johannes Ungermann, Yasmin Abou Zeed, Joshua Raoul Lindner, Marius Breitkopf, Jürgen Burhenne, Walter E. Haefeli, Rémi Longuespée |
|
| Biomedicines. 2021; 10(1): 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Can we rely on synthetic pharmacotherapy for the treatment of glioblastoma? |
|
|
| Chibueze D. Nwagwu,David C. Adamson |
|
| Expert Opinion on Pharmacotherapy. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. |
|
|
| Manendra Singh Tomar,Ashok Kumar,Chhitij Srivastava,Ashutosh Shrivastava |
|
| Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2021; : 188616 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Aggressive pituitary tumours and pituitary carcinomas |
|
|
| Gérald Raverot,Mirela Diana Ilie,Hélène Lasolle,Vincent Amodru,Jacqueline Trouillas,Frédéric Castinetti,Thierry Brue |
|
| Nature Reviews Endocrinology. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Radiotherapy-induced glioblastoma: distinct differences in overall survival, tumor location, pMGMT methylation and primary tumor epidemiology in Hong Kong chinese patients |
|
|
| Peter Y. M. Woo,Jennifer W. Y. Lee,Sandy W. Lam,Jenny K. S. Pu,Danny T. M. Chan,Calvin H. K. Mak,Jason M. K. Ho,Sui-To Wong,Yin-Chung Po,Michael W. Y. Lee,Kwong-Yau Chan,Wai-Sang Poon |
|
| British Journal of Neurosurgery. 2021; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms |
|
|
| Silvia Paukovcekova,Jan Skoda,Jakub Neradil,Erika Mikulenkova,Petr Chlapek,Jaroslav Sterba,Des R. Richardson,Renata Veselska |
|
| Cancers. 2020; 12(12): 3781 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 15 |
Revealing Temozolomide Resistance Mechanisms via Genome-Wide CRISPR Libraries |
|
|
| Clarissa Ribeiro Reily Rocha,Alexandre Reily Rocha,Matheus Molina Silva,Luciana Rodrigues Gomes,Marcela Teatin Latancia,Marina Andrade Tomaz,Izadora de Souza,Linda Karolynne Seregni Monteiro,Carlos Frederico Martins Menck |
|
| Cells. 2020; 9(12): 2573 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
